Cite
Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.
MLA
Chow, Tiffany W., et al. “Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer’s Disease Risk: A Retrospective Cohort Proof-of-Concept Study.” Pharmaceuticals (14248247), vol. 17, no. 4, Apr. 2024, p. 408. EBSCOhost, https://doi.org/10.3390/ph17040408.
APA
Chow, T. W., Raupp, M., Reynolds, M. W., Li, S., Kaeser, G. E., & Chun, J. (2024). Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer’s Disease Risk: A Retrospective Cohort Proof-of-Concept Study. Pharmaceuticals (14248247), 17(4), 408. https://doi.org/10.3390/ph17040408
Chicago
Chow, Tiffany W., Mark Raupp, Matthew W. Reynolds, Siying Li, Gwendolyn E. Kaeser, and Jerold Chun. 2024. “Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer’s Disease Risk: A Retrospective Cohort Proof-of-Concept Study.” Pharmaceuticals (14248247) 17 (4): 408. doi:10.3390/ph17040408.